Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.01% | 176.96 | 0.7% | $1383.16m | |
| MRK | Merck & Co., Inc. | 0.66% | 92.50 | 0.7% | $1203.71m | |
| PFE | Pfizer Inc. | 0.55% | 50.94 | 0.9% | $1160.82m | |
| LLY | Eli Lilly & Co. | 1.74% | 323.14 | 1.1% | $1096.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 78.28 | 1.0% | $1078.11m | |
| ABBV | AbbVie, Inc. | 0.96% | 153.95 | 1.9% | $992.07m | |
| AZN | AstraZeneca Plc | 1.65% | 67.02 | 1.0% | $451.24m | |
| SGEN | Seagen Inc. | 0.33% | 179.06 | 5.7% | $322.85m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.32% | 75.30 | 0.0% | $286.13m | |
| GSK | GSK Plc | 0.97% | 43.77 | 0.2% | $281.98m | |
| HZNP | Horizon Therapeutics Plc | 0.99% | 82.50 | 5.4% | $176.10m | |
| NVS | Novartis AG | 0.70% | 84.76 | 0.2% | $166.17m | |
| MRTX | Mirati Therapeutics, Inc. | -1.84% | 67.24 | 1.6% | $154.95m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.85% | 145.64 | 0.0% | $148.67m | |
| NVO | Novo Nordisk A/S | 1.63% | 110.06 | 0.1% | $146.95m |
Company Profile
Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.